Navigation Links
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Date:8/22/2007

ore concentrated dose and expect data from this trial in 2008."

About Catheter Occlusion

Delivery of chemotherapy, nutritional support, antibiotics and blood products, as well as the frequent withdrawal of blood samples for laboratory testing, are often facilitated via central venous catheters. Approximately five million catheters are placed in patients in the United States each year, with as many as 25 percent becoming occluded. When a catheter becomes occluded, the goal is to restore flow in a prompt and cost-effective manner with minimal risk to the patient. As these catheters are primarily inserted in patients receiving life-saving medications such as chemotherapy, it is critical to restore flow through the catheter as soon as possible. In the case of thrombotic occlusions, treatment with thrombolytic drugs represents a less-invasive and more cost-effective alternative to replacement.

About Alfimeprase

Alfimeprase is a recombinant direct acting fibrinolytic (rDAF) that has the potential to rapidly dissolve blood clots through a unique mechanism of action -- it directly degrades fibrin, a protein that provides the scaffolding for blood clots. In addition, alfimeprase's thrombolytic activity appears to be localized to the site of delivery because it is rapidly inactivated by alpha-2 macroglobulin, a naturally occurring protein in the blood, as it moves away from the site of delivery and into the general blood circulation.

In addition to catheter occlusion, alfimeprase is also being evaluated as a potential treatment for acute ischemic stroke and is in preclinical studies for acute peripheral arterial occlusion.

About Nuvelo

Nuvelo, Inc. is dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy. Nuvelo's development pipeline includes alfimeprase, a direct-acting fibrinolytic for the treatment of thrombotic-related disor
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
3. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
4. Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
5. Nuvelo Announces Presentation on NU206 at 2007 American Association for Cancer Research Annual Meeting
6. Nuvelo Announces Presentation on rNAPc2 at American College of Cardiology 56th Annual Scientific Session
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013  Healthgrades, the leading online resource that ... physicians and hospitals, today issued the Healthgrades ... Healthcare Decisions to Get Your Best Outcome . The ... maternity care, gynecologic surgery, as well as hospitals ... 15 of the most common hospital-based conditions and ...
(Date:6/18/2013)... , June 18, 2013  Isis Pharmaceuticals, Inc. (NASDAQ: ... announced that management will present a general corporate update in ... House on Tuesday, June 25 at 2:10 p.m. Pacific Time ... agenda for the meeting is as follows: 2:00 p.m. – ... record as of April 26, 2013) 2:10 p.m. – 3:15 ...
(Date:6/17/2013)... 17, 2013 DNAtrix Inc., experts in oncolytic ... clinical data on the company,s lead product, DNX-2401, at ... Quebec City, Canada on June 18, 2013. ... and a leader in the field of oncolytic virus ... A PHASE I TRIAL OF A CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS ...
Breaking Medicine Technology:Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2
... Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) and the ... have entered into a research collaboration to enable more ... cancer. The collaboration is based on ... specific spliced viral RNA molecules (i.e., RNA markers) in ...
... SEATTLE, Oct. 8 Throughout October, National Breast Cancer ... and its clinical care partner, the Seattle Cancer Care ... sheets regarding a variety of topics related to breast ... treatment, and survivorship. The series will conclude Friday, Oct. ...
Cached Medicine Technology:Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer 2Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer 310 Tips for Breast Cancer Screening and Early Detection 210 Tips for Breast Cancer Screening and Early Detection 310 Tips for Breast Cancer Screening and Early Detection 4
(Date:6/19/2013)... US Drug Watchdog says, “We have discovered a ... a recipient of a DePuy Pinnacle metal on metal hip ... and chromium, because we believe this the best way short ... the event the cobalt, or chromium levels are elevated we ... to consider, including possible revision surgery to replace the device, ...
(Date:6/19/2013)... National Camp Series (NCS) Associate ... The Dream’s effort to fight ovarian cancer according to NFL ... "We are excited to have Dan jump on board,” says ... young specialists; great example, great purpose. That is exactly what ... Zeidman says Kicking For The Dream is definitely ...
(Date:6/18/2013)... Los Angeles, CA (PRWEB) June 19, 2013 ... field of bariatric surgery, are holding complimentary weight loss ... dates, the detailed program can be accessed at their ... that minimizes surgery and recovery time. Their highly skilled ... approach to bariatric surgery. , A senior executive ...
(Date:6/18/2013)... 19, 2013 Parker Waichman LLP, a ... victims injured by dangerous drugs and medical devices, has ... who alleges that she was injured by transvaginal ... 30th in the U.S. District Court for the Southern ... the multidistrict litigation entitled In Re: American Medical Systems, ...
(Date:6/18/2013)... As obesity rates sky rocket in the ... equipment during childbirth comes as no shock. Forceps are surgical ... when she is unable to do so herself and although ... higher rates of complication for both the mother and the ... mother and child, forceps births add to the pressure of ...
Breaking Medicine News(10 mins):Health News:US Drug Watchdog Now Urges Recipients Of A DePuy Pinnacle All Metal Hip Implant To Call Them About A Vital Blood Test To See If Their Hip Implant Device Has Failed 2Health News:National Camp Series (NCS) Associate Dan Zeidman of Lifetime Kicking Academy Joins Kicking For The Dream’s Effort to Fight Ovarian Cancer 2Health News:National Camp Series (NCS) Associate Dan Zeidman of Lifetime Kicking Academy Joins Kicking For The Dream’s Effort to Fight Ovarian Cancer 3Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2
... The holiday season can be a time full of joy, ... those recovering from an eating disorder, it,s a time of ... uncertain future. Family gatherings with a loved one in recovery ... , "In my practice, I have even seen ...
... , SAN FRANCISCO, Nov. 24 ... and services provider, announced today that it has licensed ... of Michigan for integration into Quantros, suite of safety ... software within the SRM product family will enable automated ...
... , LAKE SUCCESS, N.Y., Nov. 24 ... certification, an international quality management standard focused on ... improving business performance. Certification to ISO 9001:2008 ... Management System (QMS) has passed a rigorous external ...
... sedatives, antidepressants, benzodiazepines, review finds , TUESDAY, Nov. ... sedatives and other psychotropic medications may be at ... , Canadian researchers analyzed 22 published studies that ... 60. The studies evaluated nine classes of drugs: ...
... Pa., Nov. 24 Governor Edward G. Rendell today ... were vaccinated during the weekend at public health clinics ... departments. , "With the federal government unable to ... H1N1 vaccine, distribution has been challenging," said Governor Rendell. ...
... While the holiday season often brings families and friends ... difficult for those grieving the death of a loved one. ... families. The holiday season can bring additional challenges to those ... for Grieving Children, Adolescents and Their Families, is available for ...
Cached Medicine News:Health News:When Holiday Meals Aren't a Gift 2Health News:When Holiday Meals Aren't a Gift 3Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 3Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2
For restriction digests, immuno-precipitations, enzyme assays, TLC spotting and others...
The Ultra Micro tip for the Eppendorf and Nichiryo/BenchMate 0.5-10 L pipettors is perfect for working with low volume samples....
... The easy way to order tips. Each ... tips)except for D10mL, which contains 200 tips (4 ... re-sealable Bulk Packs of 200 tips per pack. ... which can easily be opened for quick access ...
... The economical way to order tips. Each ... 1000 tips). Also available in easy-to-open, re-sealable ... Bulk Packs are sealed with a tamper-proof ... quick access to Gilsons Diamond Tips. Bulk ...
Medicine Products: